Dogwood Therapeutics Inc (NASDAQ:DWTX) currently has a daily average trading volume of 3.55M but it saw 7284963 shares traded in last market. With a market cap of 14.26M USD, the company’s current market price of $10.70 came falling about -3.86 while comparing to the previous closing price of $11.13. In past 52 weeks, the stock remained buoying in the range of price level as high as $29.28 and as low as $1.62. In the recent trading on the day, stock has struck highest price mark of $10.14 while lowest mark touched by it was $14.69.
Taking a look at 20-day trading activity of Dogwood Therapeutics Inc (DWTX) gives us an average price of $6.11, while its current price level is -63.46% below from 52-week high level whereas it is 560.49% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $6.69 while that of 200 days or SMA-200 reads an average of $5.07. A closer look into the stock’s movement over the week reveals that its volatility is standing at 51.61% during that period while stretching the period over a month that decreases to 23.07%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 66.48 which implies that the stock is in neutral territory.
Over the week, DWTX’s stock price is moving 140.45% up while it is 22.01% when we observe its performance for the past one month. Year-to-date it is 329.72% up and over the past year, the stock is showing an upside performance of 15.99%.
The company is expected to be releasing its next quarterly report on 2025-Mar-11, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Dogwood Therapeutics Inc’s total number of outstanding shares is 1.11M with 21.48% of that held by the insiders while 2.32% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -603.00% and return on equity (ROE) at -200.48%. Stock’s beta reads 1.13. Stock has a price to book (P/B) ratio of 12.51. Its return on asset (ROA) is -152.02% on average.
